Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...
A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a ...
The news was reported by Bloomberg late Wednesday, citing people familiar with the matter. In the final days of President Joe Biden's term, Moderna (MRNA) won the $590 million contract to use its mRNA ...
Robert F Kennedy Jr has issued a 90-day pause for a $200million Biden-era contract with Vaxart Inc to develop a new oral ...
Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...
Taiwanese scientists have discovered a new way to synthesize circular RNA (circRNA), which could be applied to vaccine ...
More than 2.7 million confirmed national cases of Covid-19 have been logged since our very first was announced on February 28 ...
11h
Axios on MSNFunding for Moderna bird flu vaccine under reviewThe Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final ...
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results